Sponsor Pipeline

Shanghai Kechow Pharma, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
2
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06008106 Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant… Melanoma Recruiting
NCT06008119 Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant… Colorectal Cancer Metastatic Recruiting
Phase 2
NCT05331105 HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform… Neurofibromatosis 1 Recruiting
Phase 1
NCT06867393 Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects Healthy Subjects Recruiting
Disease Areas
Melanoma (1) Colorectal Cancer (1)
Get alerts when Shanghai Kechow Pharma, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free